Content about Pain

January 23, 2014

In a recent report, 59News explored how DEA regulations on pain medications can limit a pharmacy's supply, preventing patients from obtaining their medications.

In a recent report, 59News explored how DEA regulations on pain medications can limit a pharmacy's supply, preventing patients from obtaining their medications.

January 2, 2014

One reason pain patient advocates are so passionate about what they do is because they are pain patients themselves — they know the stigma associated with chronic pain

Audio Q&A: One reason pain patient advocates are so passionate about what they do is because they are pain patients themselves — they know the stigma associated with chronic pain; they know how difficult it can be to access appropriate pain therapy sometimes. That’s the story of Gina Libby, volunteer pain patient advocate who has lived with chronic pain for more than 20 years.

April 9, 2014

GM Pharmaceuticals recently announced the addition of 8-oz. bottles to its line of liquid pain relief VanaPain.

ARLINGTON, Texas — GM Pharmaceuticals recently announced the addition of 8-oz. bottles to its line of liquid pain relief VanaPain. The new bulk products for the chronic pain sufferer begin shipping in July, and the suggested retail price ranges from $7.99 to $9.99. 

March 28, 2014

DSN recently launched a new microsite, DrugStoreNews.com/Pain-Management, to bring attention to a tragic side of the prescription drug abuse story — one that's not often told. The millions of Americans who live in chronic pain who already find it difficult to access the medications they need may soon find it even more difficult — because proposed changes in regulatory policy are expected to place additional hurdles on their treatment pathway.

DSN recently launched a new microsite, DrugStoreNews.com/Pain-Management, to bring attention to a tragic side of the prescription drug abuse story — one that's not often told.

March 27, 2014

A study from Wahl Therapeutic Massagers released Thursday found that physical aches and soreness are a real threat to travelers of all ages — 92% of adults 18 years of age and older experience physical pain while traveling.

STERLING, Ill. — A study from Wahl Therapeutic Massagers released Thursday found that physical aches and soreness are a real threat to travelers of all ages — 92% of adults 18 years of age and older experience physical pain while traveling.

March 25, 2014

The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring attention to another tragic side of the prescription drug abuse story — the millions of Americans who live in chronic pain that may be unable to access the medications they need thanks to proposed changes in regulatory policy.

NEW YORK — The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring attention to another tragic side of the prescription drug abuse story — the millions of Americans who live in chronic pain that may be unable to access the medications they need thanks to proposed changes in regulatory policy.

March 25, 2014

VR1 on Tuesday announced the availability of Ausanil, a new non-prescription homeopathic nasal spray formulated to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions.

NEW YORK — VR1 on Tuesday announced the availability of Ausanil, a new non-prescription homeopathic nasal spray formulated to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions. 

March 20, 2014

Purdue Pharma recently announced that a Phase 3 study of an investigational extended‐release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once‐daily analgesic agent experienced statistically significant reduction in pain compared with placebo.

STAMFORD, Conn. — Purdue Pharma recently announced that a Phase 3 study of an investigational extended‐release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once‐daily analgesic agent experienced statistically significant reduction in pain compared with placebo. 

March 18, 2014

Mallinckrodt Plc last week announced that the Food and Drug Administration approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), for the management of acute pain severe enough that it requires opioid treatment.

DUBLIN — Mallinckrodt Plc last week announced that the Food and Drug Administration approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), for the management of acute pain severe enough that it requires opioid treatment.

The drug also is indicated for patients for whom alternative treatments have shown to be ineffective. Xartemis XR, previously known as MNK-795, is the first and only extended-release oral combination of two clinically proven pain medications — oxycodone and acetaminophen.

March 11, 2014

A survey by the National Pain Foundation of more than 300 people who live with chronic pain is shedding light on how chronic pain sufferers are treated by their healthcare providers.

GOLDEN, Colo. — A survey by the National Pain Foundation of more than 300 people who live with chronic pain is shedding light on how chronic pain sufferers are treated by their healthcare providers.  

The findings revealed that pain patients are uncomfortable when visiting their pharmacy. Fifty-two percent said they "are concerned that they will be treated like a drug addict by their pharmacist," with 29% expressing concern that they would "be embarrassed by their pharmacist."

March 7, 2014

BioElectronics, maker of consumer medical devices and drug-free pain therapies, earlier this week announced that it is participating in upcoming consumer educational events and programs as part of an international campaign to discuss alternative pain modalities.

FREDERICK, Md. — BioElectronics, maker of consumer medical devices and drug-free pain therapies, earlier this week announced that it is participating in upcoming consumer educational events and programs as part of an international campaign to discuss alternative pain modalities.

March 5, 2014

Most people who abuse prescription opioid drugs get them for free from a friend or relative — but those at highest risk of overdose are as likely to get them from a doctor’s prescription, Centers for Disease Control researchers reported Monday in a research letter, “Sources of Prescription Opioid Pain Relievers by Frequency of Past-Year Nonmedical Use: United States, 2008-2011,” in the Journal of the American Medical Association Internal Medicine.

ATLANTA — Most people who abuse prescription opioid drugs get them for free from a friend or relative — but those at highest risk of overdose are as likely to get them from a doctor’s prescription, Centers for Disease Control researchers reported Monday in a research letter, “Sources of Prescription Opioid Pain Relievers by Frequency of Past-Year Nonmedical Use: United States, 2008-2011,” in the Journal of the American Medical Association Internal Medicine.

February 27, 2014

A long-term study by UCLA, in collaboration with the University of Aarhus in Denmark, has raised concerns about the use of acetaminophen during pregnancy, UCLA announced earlier this week.

LOS ANGELES — A long-term study by UCLA, in collaboration with the University of Aarhus in Denmark, has raised concerns about the use of acetaminophen during pregnancy, UCLA announced earlier this week.  

In a report in the current online edition of JAMA Pediatrics, researchers from the UCLA Fielding School of Public Health show that taking acetaminophen during pregnancy is associated with a higher risk in children of attention-deficity/hyperactivity disorder and hyperkinetic disorder.  

February 25, 2014

New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage.

WASHINGTON — New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage. A nationwide consumer survey conducted by the Consumer Healthcare Products Association Educational Foundation, in conjunction with its work on the Acetaminophen Awareness Coalition’s Know Your Dose educational campaign, shows that consumer safe use knowledge and risk awareness has increased over a three year period (2010-2013).

February 13, 2014

After meeting for two days earlier this week, the Food and Drug Administration's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 16-9 against changing the label of naproxen to highlight a lower cardiovascular risk profile as compared to other NSAIDs, according to published reports.

SILVER SPRING, Md. — After meeting for two days earlier this week, the Food and Drug Administration's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 16-9 against changing the label of naproxen to highlight a lower cardiovascular risk profile as compared to other NSAIDs, according to published reports. 

Those advisory panels who voted against the change felt the data were insufficient to say naproxen was safer than other NSAIDs.

February 10, 2014

DenTek will be launching a new DenTek Adult Benzocaine solution in March, the company announced last week.

MARYVILLE, Tenn. — DenTek will be launching a new DenTek Adult Benzocaine solution in March, the company announced last week. 

DenTek Adult Benzocaine is a maximum strength instant pain reliever that features an applicator to apply the active effortlessly with no mess. The disposable applicators guarantee precise and sanitary application every time, the company stated. 

February 10, 2014

Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.

ROCKVILLE, Md. — Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health. 

The study was published Feb. 6 in the Journal of the National Cancer Institute.

February 6, 2014

The Associated Press on Tuesday reported that New York's online database of drug prescriptions has curtailed "doctor shopping" by 75%, citing New York Health Commissioner Nirav Shah.

ALBANY, N.Y. — The Associated Press on Tuesday reported that New York's online database of drug prescriptions has curtailed "doctor shopping" by 75%, citing New York Health Commissioner Nirav Shah. 

The Internet System for Tracking Over-Prescribing, called I-STOP, began operating in August, AP reported. 

January 29, 2014

Omron Healthcare on Tuesday announced the release of its new Pain Relief Pro electroTHERAPY unit.

LAKE FOREST, Ill. — Omron Healthcare on Tuesday announced the release of its new Pain Relief Pro electroTHERAPY unit. Its versatility delivers more settings and more power for more relief with 10 power levels and eight pre-set modes.

January 17, 2014

Patients with fibromyalgia syndrome typically have widespread chronic pain and fatigue. For those with low vitamin D levels, vitamin D supplements can reduce pain and may be a cost-effective alternative or adjunct to other treatment, reported researchers in the current issue of PAIN.

PHILADELPHIA — Patients with fibromyalgia syndrome typically have widespread chronic pain and fatigue. For those with low vitamin D levels, vitamin D supplements can reduce pain and may be a cost-effective alternative or adjunct to other treatment, reported researchers in the current issue of Pain.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

NEW YORK — News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds.

December 11, 2013

First Aid Shot Therapy on Wednesday announced the launch of its F.A.S.T. Pain Relief product, a berry-flavored, single-dose, liquid relief shot.

SEATTLE — First Aid Shot Therapy on Wednesday announced the launch of its F.A.S.T. Pain Relief product, a berry-flavored, single-dose, liquid relief shot. According to the company, F.A.S.T.'s active ingredient choline salicylate may enter a person's blood stream up to five times faster than aspirin. 

December 4, 2013

Dennis Kinch lives by the motto, "Do what you can, when you can." These seven words have carried him through hardships and triumphs. In 2005-2006, they even spearheaded his crusade to walk the entire Route 66 to raise awareness about chronic pain.

Dennis Kinch lives by the motto, "Do what you can, when you can." These seven words have carried him through hardships and triumphs. In 2005-2006, they even spearheaded his crusade to walk the entire Route 66 to raise awareness about chronic pain.

December 4, 2013

For decades, Radene Marie Cook had two complimentary careers: she was a professional actress, dancer and singer in southern California, and she enjoyed a 16-year run as an on-air radio personality, including time spent as an "on the spot" news and traffic airborne reporter for KFWB in Los Angeles. In January of 2000, she won two broadcast awards for her work.

But on March 16, 2000, all that changed.

For decades, Radene Marie Cook had two complimentary careers: she was a professional actress, dancer and singer in southern California, and she enjoyed a 16-year run as an on-air radio personality, including time spent as an "on the spot" news and traffic airborne reporter for KFWB in Los Angeles. In January of 2000, she won two broadcast awards for her work.

December 4, 2013

At 42 years old, Gina Libby has lived with chronic pain for more than 20 years. Yet, it hasn't stopped her from making an impact; she's on the front lines of pain advocacy, using her experience to influence healthcare policy and teach others.

At 42 years old, Gina Libby has lived with chronic pain for more than 20 years. Yet, it hasn't stopped her from making an impact; she's on the front lines of pain advocacy, using her experience to influence healthcare policy and teach others.